Ensol Biosciences Inc. (XKON:140610)
14,200
+200 (1.43%)
At close: Apr 24, 2026
-43.09% (1Y)
| Market Cap | 192.35B -33.5% |
| Revenue (ttm) | 537.46M +208.9% |
| Net Income | -5.40B |
| EPS | -644.00 |
| Shares Out | 13.55M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,462 |
| Average Volume | 5,660 |
| Open | 14,000 |
| Previous Close | 14,000 |
| Day's Range | 13,900 - 14,490 |
| 52-Week Range | 10,350 - 38,800 |
| Beta | 0.82 |
| RSI | 51.88 |
| Earnings Date | n/a |